Patent · US Expired

Laminin 15

US6635616B2 · kind B2 · utility

0Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2001
Grant dateOct 21, 2003
Priority date
Expiry dateApr 30, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/78
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features a novel member of the laminin family, i.e., laminin 15, the methods of making these molecules, and the methods of using these molecules in treating neural disorders, e.g., retinal disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.